• Andrew Wilner, MD

Angiogenesis and COVID-19

I had the pleasure of interviewing Dr. William Li, President and Medical Director of the Angiogenesis Foundation, about his recent NEJM article about COVID-19. Dr. Li and colleagues examined the lungs of 7 patients with COVID-19 obtained at autopsy and compared them to lungs of patients who had died by the flu as well as normal controls. COVID-19 lungs had distinctive vascular features that included severe endothelial injury and disrupted cell membranes. There was also widespread microangiopathy and excess of new vessel growth, 2.7 times higher than the lungs of patients who died from influenza (p<0.001). These findings speak to the question of whether COVID-19 patients should be anticoagulated to prevent thrombotic events such as COVID toe, DVT, PE, and large vessel stroke. To hear our 20 minute discussion, please follow this link to our Medscape interview: https://www.medscape.com/viewarticle/931591


#Covid19 #angiogenesis #angiogenesisfoundation #COVIDtoe #stroke #largevesselocclusion


57 views

        Ask a question!                                      For  media inquiries,

                                    please contact the author:

Disclaimer: The author's website and books do not intend to provide professional business, medical, or legal advice and should not replace the counsel of an accountant, physician, or attorney, repsectively. Although these books have been carefully researched, the author assumes no liability for loss or damages resulting from their use.

 

As an Amazon Associate, I earn from qualifying purchases.

Copywrite: Andrew Wilner, MD 2019.